| Product NDC: | 24987-262 |
| Proprietary Name: | LANOXIN |
| Non Proprietary Name: | digoxin |
| Active Ingredient(s): | 100 ug/mL & nbsp; digoxin |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 24987-262 |
| Labeler Name: | Covis Pharmaceuticals Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA009330 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130114 |
| Package NDC: | 24987-262-10 |
| Package Description: | 10 AMPULE in 1 BOX (24987-262-10) > 1 mL in 1 AMPULE |
| NDC Code | 24987-262-10 |
| Proprietary Name | LANOXIN |
| Package Description | 10 AMPULE in 1 BOX (24987-262-10) > 1 mL in 1 AMPULE |
| Product NDC | 24987-262 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | digoxin |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20130114 |
| Marketing Category Name | NDA |
| Labeler Name | Covis Pharmaceuticals Inc |
| Substance Name | DIGOXIN |
| Strength Number | 100 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |